These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1042 related items for PubMed ID: 27297224

  • 1. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

  • 2. Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.
    Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, Humberg A, Benz K, Krause M, Pohl M, Liebau MC, Schild R, Lemke J, Beringer O, Müller D, Härtel C, Wigger M, Vester U, Konrad M, Haffner D, Pape L, Oh J, Kemper MJ.
    Clin Infect Dis; 2017 Jun 15; 64(12):1637-1643. PubMed ID: 28329394
    [Abstract] [Full Text] [Related]

  • 3. Hemolytic uremic syndrome in children.
    Talarico V, Aloe M, Monzani A, Miniero R, Bona G.
    Minerva Pediatr; 2016 Dec 15; 68(6):441-455. PubMed ID: 27768015
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.
    Rosales A, Kuppelwieser S, Giner T, Hofer J, Riedl Khursigara M, Orth-Höller D, Borena W, Cortina G, Jungraithmayr T, Würzner R, German-Austrian H. U. S.-Study Group.
    Pediatr Nephrol; 2024 Aug 15; 39(8):2459-2465. PubMed ID: 38589699
    [Abstract] [Full Text] [Related]

  • 6. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.
    Pediatrics; 2005 Jun 15; 115(6):e673-80. PubMed ID: 15930195
    [Abstract] [Full Text] [Related]

  • 7. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A, Ranchin B, King LA, Bacchetta J, Belot A, Gillet Y, Collardeau-Frachon S, Cochat P.
    Arch Pediatr; 2011 Jul 15; 18(7):823-30. PubMed ID: 21571510
    [Abstract] [Full Text] [Related]

  • 8. Diarrhoea-associated haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infections in New Zealand children: Clinical features and short-term complications from a 23-year cohort study.
    Wong W, Prestidge C, Dickens A, Ronaldson J.
    J Paediatr Child Health; 2023 Mar 15; 59(3):493-498. PubMed ID: 36655863
    [Abstract] [Full Text] [Related]

  • 9. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance.
    Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L.
    BMC Infect Dis; 2014 May 16; 14():265. PubMed ID: 24884396
    [Abstract] [Full Text] [Related]

  • 10. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C.
    Acta Biomed; 2018 Dec 17; 89(9-S):153-157. PubMed ID: 30561409
    [Abstract] [Full Text] [Related]

  • 11. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
    Derad I, Obermann B, Katalinic A, Eisemann N, Knobloch JK, Sayk F, Wellhöner P, Lehnert H, Solbach W, Süfke S, Steinhoff J, Nitschke M.
    Nephrol Dial Transplant; 2016 Jan 17; 31(1):95-103. PubMed ID: 26180049
    [Abstract] [Full Text] [Related]

  • 12. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M, Andreoli S.
    Pediatr Nephrol; 2019 Dec 17; 34(12):2495-2507. PubMed ID: 30382336
    [Abstract] [Full Text] [Related]

  • 13. CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016.
    Chokoshvili O, Vepkhvadze N, Davitaia T, Tevzadze L, Tsertsvadze T.
    Georgian Med News; 2018 Oct 17; (283):123-129. PubMed ID: 30516507
    [Abstract] [Full Text] [Related]

  • 14. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
    Ağbaş A, Göknar N, Akıncı N, Yıldırım ZY, Taşdemir M, Benzer M, Gökçe İ, Candan C, Küçük N, Uzuner S, Özçelik G, Demirkol D, Sever L, Çalışkan S.
    Pediatr Nephrol; 2018 Dec 17; 33(12):2371-2381. PubMed ID: 30159625
    [Abstract] [Full Text] [Related]

  • 15. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H.
    Pediatr Nephrol; 2020 Sep 17; 35(9):1749-1759. PubMed ID: 32323005
    [Abstract] [Full Text] [Related]

  • 16. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.
    Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF.
    JAMA; 2003 Sep 10; 290(10):1360-70. PubMed ID: 12966129
    [Abstract] [Full Text] [Related]

  • 17. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
    Peco-Antić A.
    Srp Arh Celok Lek; 2016 Sep 10; 144(11-12):664-9. PubMed ID: 29659236
    [Abstract] [Full Text] [Related]

  • 18. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
    Luna M, Kamariski M, Principi I, Bocanegra V, Vallés PG.
    Pediatr Nephrol; 2021 Jun 10; 36(6):1499-1509. PubMed ID: 33205220
    [Abstract] [Full Text] [Related]

  • 19. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C.
    Med Mal Infect; 2018 May 10; 48(3):167-174. PubMed ID: 29054297
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome.
    Liu Y, Thaker H, Wang C, Xu Z, Dong M.
    Toxins (Basel); 2022 Dec 23; 15(1):. PubMed ID: 36668830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.